12 citations as recorded by crossref.

1. Flucloxacillin bone and soft tissue concentrations assessed by microdialysis in pigs after intravenous and oral administration M. Bendtsen et al.
2. Reflections on the Theoretical Prerequisites for Initial Oral Antibiotic Treatment for Paediatric Bone and Joint Infections: A Narrative Review P. Rodriguez et al.
3. Staphylococcus aureus vertebral osteomyelitis: a single-centre retrospective cohort study with focus on oral flucloxacillin follow-up J. Wern et al.
4. Oral Flucloxacillin for Staphylococcal Osteomyelitis: Obsolete or Underused? S. Tevell & B. Christensson
5. Population Pharmacokinetics of Flucloxacillin In Bone and Soft Tissue– Standard Dosing is Not Sufficient to Achieve Therapeutic Concentrations K. Öbrink-Hansen et al.
6. Negligible Substituent Effect as Key to Synthetic Versatility: a Computational‐Experimental Study of Vinyl Ethers Addition to Nitrile Oxides A. Kutskaya et al.
7. Not recommended fixed-dose antibiotic combinations in low- and middle-income countries – the example of Tanzania K. Vliegenthart-Jongbloed & J. Jacobs
8. Initial antibiotic therapy for postoperative moderate or severe diabetic foot infections: Broad versus narrow spectrum, empirical versus targeted A. Nieuwland et al.
9. Population pharmacokinetics of free flucloxacillin in patients treated with oral flucloxacillin plus probenecid P. Drennan et al.
10. Assessment and management of diabetes‐related foot infection according to the new International Working Group on the Diabetic Foot guidelines 2023—Multidisciplinary grand rounds K. Hon et al.
11. Steady-state concentrations of flucloxacillin in porcine vertebral cancellous bone and intervertebral disc following oral and intravenous administration assessed by microdialysis M. Bendtsen et al.
12. Three Weeks Versus Six Weeks of Antibiotic Therapy for Diabetic Foot Osteomyelitis: A Prospective, Randomized, Noninferiority Pilot Trial K. Gariani et al.